Dynavax (NASDAQ: DVAX) is gaining 5% Monday, likely related to a competitor's failure.RBC Capital analyst Brian Abrahams notes "VBI Vaccines ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE